Theralink Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch THER and buy or sell other stocks, ETFs, and their options commission-free!

About THER

Theralink Technologies, Inc. is a precision medicine company, which engages in the development of novel cancer immunotherapy products. It offers the reverse phase protein array technology platform that can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. 

CEO
Faith Zaslavsky
CEOFaith Zaslavsky
Employees
16
Employees16
Headquarters
Golden, Colorado
HeadquartersGolden, Colorado
Founded
2005
Founded2005
Employees
16
Employees16

THER Key Statistics

Market cap
0.00
Market cap0.00
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
277.78
Average volume277.78
High today
High today
Low today
Low today
Open price
Open price
Volume
2.50K
Volume2.50K
52 Week high
$0.001
52 Week high$0.001
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

As of today, Theralink Technologies(THER) shares are valued at $0.00. The company's market cap stands at 0.

During the trading day, Theralink Technologies(THER) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 2.5K, compared to an average daily volume of 277.78.

Over the past 52 weeks, Theralink Technologies(THER) stock has traded between a high of $0.00 and a low of $0.00.

Over the past 52 weeks, Theralink Technologies(THER) stock has traded between a high of $0.00 and a low of $0.00.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.